{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T04:40:37Z","timestamp":1765428037311,"version":"3.46.0"},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MIRNA"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Gaucher disease (GD) occurs due to a mutation in the glucosylcerami-dase (GBA) gene and is a common lysosomal storage disease. It is well known that there is a strong association between the abnormal expression of miRNAs and various diseases including cancer. These abnormally expressed miRNAs can be used as biomarkers. Interestingly, several studies have reported a linkage between GD with an increased risk of cancer. Therefore, in the current study, we investigated the expression levels of selected miRNAs that are associated with cancers that might have potential use as biomarkers in GD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Blood samples were collected from 24 healthy volunteers, 6 carriers, and 20 treated patients with type 1 GD. A reverse transcription-quantitative real-time PCR (RT-qPCR) platform was used to analyze the miRNA expression levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>While carriers had lower relative expressions of miRNA-15a with tumor suppressor ef-fect, and miRNA-150 and miRNA-181b with oncogene effect, treated patients with type 1 GD had lower relative expressions of miRNA-15a and miRNA-125b with tumor suppressor effect and higher relative expression miRNA-21 with oncogene effect (p&lt;0.001, p&lt;0.05, p&lt;0.01, p&lt;0.05, p&lt;0.001, and p&lt;0.05, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results suggested that the downregulation of miRNA-15a and miRNA-125b expressions with tumor suppressor effect and the upregulation of miRNA-21 expression with on-cogene effect can be indicated to an increased risk for cancers such as multiple myeloma (MM), B-cell lymphoma, leukemia, and hepatocellular carcinoma (HCC) in GD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0122115366342286250216032611","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T02:43:42Z","timestamp":1740624222000},"page":"246-253","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor Suppressor and Oncogenic miRNA Expressions in Patients with Type I Gaucher Disease and Carriers"],"prefix":"10.2174","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-1361","authenticated-orcid":true,"given":"Ramazan","family":"\u00dczen","sequence":"first","affiliation":[{"name":"Department of Medical Biology, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey"},{"name":"100\/2000 CoHE PhD Scholarship Program, Institute of Health Sciences, 38030, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-6744","authenticated-orcid":true,"given":"Fahri","family":"Bayram","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-0883","authenticated-orcid":true,"given":"Huseyin","family":"Dursun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2276-7611","authenticated-orcid":true,"given":"Fatih","family":"Kardas","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nutrition and Metabolism, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-5485","authenticated-orcid":true,"given":"Mustafa","family":"Cakir","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical Faculty, Van Yuzuncu Y\u0131l University, 65080 Van, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-085X","authenticated-orcid":true,"given":"Md Mahmodul","family":"Hasan Sohel","sequence":"additional","affiliation":[{"name":"Bet\u00fcl-Ziya Eren Genome and Stem Cell Research Center, Erciyes University, 38030 Kayseri, Turkey"},{"name":"Department of Life Sciences, School of Environment and Life Sciences, Independent University, Bangladesh, Dhaka, Bangladesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-9187","authenticated-orcid":true,"given":"Nurhan","family":"Cucer","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-0686","authenticated-orcid":true,"given":"Ahmet","family":"Eken","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey"},{"name":"Bet\u00fcl-Ziya Eren Genome and Stem Cell Research Center, Erciyes University, 38030 Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6473-5813","authenticated-orcid":true,"given":"Hamiyet","family":"Donmez-Altuntas","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey"},{"name":"Bet\u00fcl-Ziya Eren Genome and Stem Cell Research Center, Erciyes University, 38030 Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"Stirnemann J.","year":"2017","unstructured":"Stirnemann J.; Belmatoug N.; Camou F.; A review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci  2017,18(2),441","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cca.2020.03.016","volume":"506","author":"Huang Y.","year":"2020","unstructured":"Huang Y.; Jia X.; Tang C.; High risk screening for Gaucher disease in patients with splenomegaly and\/or thrombocytopenia in China: 55 cases identified. Clin Chim Acta  2020,506(February),22-27","journal-title":"Clin Chim Acta"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/10428190600565453","volume":"47","author":"Costello R.","year":"2006","unstructured":"Costello R.; O\u2019Callaghan T.; S\u00e9bahoun G.; Gaucher disease and multiple myeloma. Leuk Lymphoma  2006,47(7),1365-1368","journal-title":"Leuk Lymphoma"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","volume":"18","author":"Mistry P.K.","year":"2013","unstructured":"Mistry P.K.; Taddei T.; vom Dahl S.; Rosenbloom B.E.; Gaucher disease and malignancy: A model for cancer pathogenesis in an inborn error of metabolism. Crit Rev Oncog  2013,18(3),235-246","journal-title":"Crit Rev Oncog"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/bjh.12335","volume":"161","author":"Arends M.","year":"2013","unstructured":"Arends M.; van Dussen L.; Biegstraaten M.; Hollak C.E.M.; Malignancies and monoclonal gammopathy in G aucher disease; a systematic review of the literature. Br J Haematol  2013,161(6),832-842","journal-title":"Br J Haematol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1615\/CritRevOncog.2013005814","volume":"18","author":"Barth B.M.","year":"2013","unstructured":"Barth B.M.; Shanmugavelandy S.S.; Tacelosky D.M.; Kester M.; Morad S.A.F.; Cabot M.C.; Gaucher\u2019s disease and cancer: A sphingolipid perspective. Crit Rev Oncog  2013,18(3),221-234","journal-title":"Crit Rev Oncog"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms20040843","volume":"20","author":"W\u0105tek M.","year":"2019","unstructured":"W\u0105tek M.; Piktel E.; Wollny T.; Defective sphingolipids metabolism and tumor associated macrophages as the possible links between gaucher disease and blood cancer development. Int J Mol Sci  2019,20(4),843","journal-title":"Int J Mol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/cancers12020475","volume":"12","author":"Dubot P.","year":"2020","unstructured":"Dubot P.; Astudillo L.; Therville N.; Are glucosylceramide-related sphingolipids involved in the increased risk for cancer in gaucher disease patients? Review and hypotheses. Cancers  2020,12(2),475","journal-title":"Cancers"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"Lu T.X.","year":"2018","unstructured":"Lu T.X.; Rothenberg M.E.; MicroRNA. J Allergy Clin Immunol  2018,141(4),1202-1207","journal-title":"J Allergy Clin Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"109995","DOI":"10.1016\/j.cellsig.2021.109995","volume":"83","author":"Budakoti M.","year":"2021","unstructured":"Budakoti M.; Panwar A.S.; Molpa D.; Micro-RNA: The darkhorse of cancer. Cell Signal  2021,83(January),109995","journal-title":"Cell Signal"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymgme.2017.07.012","volume":"122","author":"Hassan S.","year":"2017","unstructured":"Hassan S.; Sidransky E.; Tayebi N.; The role of epigenetics in lysosomal storage disorders: Uncharted territory. Mol Genet Metab  2017,122(3),10-18","journal-title":"Mol Genet Metab"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/aps.2018.30","volume":"39","author":"Zhou S.","year":"2018","unstructured":"Zhou S.; Jin J.; Wang J.; miRNAS in cardiovascular diseases: Potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin  2018,39(7),1073-1084","journal-title":"Acta Pharmacol Sin"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s12035-022-02727-4","volume":"59","author":"Khezri M.R.","year":"2022","unstructured":"Khezri M.R.; Yousefi K.; Zolbanin N.M.; Ghasemnejad-Berenji M.; MicroRNAs in the pathophysiology of Alzheimer\u2019s disease and Parkinson\u2019s disease: An overview. Mol Neurobiol  2022,59(3),1589-1603","journal-title":"Mol Neurobiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11926-021-01009-7","volume":"23","author":"Saquib M.","year":"2021","unstructured":"Saquib M.; Agnihotri P.; Monu, Biswas S. Exogenous miRNA: A perspective role as therapeutic in rheumatoid arthritis. Curr Rheumatol Rep  2021,23(6),43","journal-title":"Curr Rheumatol Rep"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"117473","DOI":"10.1016\/j.lfs.2020.117473","volume":"248","author":"Sohel M.M.H.","year":"2020","unstructured":"Sohel M.M.H.; Circulating microRNAs as biomarkers in cancer diagnosis. Life Sci  2020,248(January),117473","journal-title":"Life Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/life11010002","volume":"11","author":"Pawli\u0144ski \u0141.","year":"2020","unstructured":"Pawli\u0144ski \u0141.; Polus A.; Tob\u00f3r E.; MiRNA expression in patients with Gaucher disease treated with enzyme replacement therapy. Life  2020,11(1),2","journal-title":"Life"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcancer.2017.09.007","volume":"51","author":"Alzrigat M.","year":"2018","unstructured":"Alzrigat M.; P\u00e1rraga A.A.; Jernberg-Wiklund H.; Epigenetics in multiple myeloma: From mechanisms to therapy. Semin Cancer Biol  2018,51,101-115","journal-title":"Semin Cancer Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.3748\/wjg.v19.i33.5439","volume":"19","author":"Khare S.","year":"2013","unstructured":"Khare S.; Zhang Q.; Ibdah J.A.; Epigenetics of hepatocellular carcinoma: Role of microRNA. World J Gastroenterol  2013,19(33),5439-5445","journal-title":"World J Gastroenterol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12859-019-3041-9","volume":"20","author":"Lei H.","year":"2019","unstructured":"Lei H.; Liu W.; Si J.; Wang J.; Zhang T.; Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma. BMC Bioinformatics  2019,20(1),449","journal-title":"BMC Bioinformatics"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/leu.2014.351","volume":"29","author":"Musilova K.","year":"2015","unstructured":"Musilova K.; Mraz M.; MicroRNAs in B-cell lymphomas: How a complex biology gets more complex. Leukemia  2015,29(5),1004-1017","journal-title":"Leukemia"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.livres.2018.06.002","volume":"2","author":"Tao J.","year":"2018","unstructured":"Tao J.; Jiang L.; Chen X.; Roles of microRNA in liver cancer. Liver Res  2018,2(2),61-72","journal-title":"Liver Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1002\/jcp.26290","volume":"233","author":"Ultimo S.","year":"2018","unstructured":"Ultimo S.; Martelli A.M.; Zauli G.; Vitale M.; Calin G.A.; Neri L.M.; Roles and clinical implications of microRNAs in acute lymphoblastic leukemia. J Cell Physiol  2018,233(8),5642-5654","journal-title":"J Cell Physiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3389\/fimmu.2018.00936","volume":"9","author":"Zheng B.","year":"2018","unstructured":"Zheng B.; Xi Z.; Liu R.; The function of microRNAs in B-cell development, lymphoma, and their potential in clinical practice. Front Immunol  2018,9(APR),936","journal-title":"Front Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.3892\/ol.2018.8157","volume":"15","author":"Zhu B.","year":"2018","unstructured":"Zhu B.; Ju S.; Chu H.; The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma (Review). Oncol Lett  2018,15(5),6094-6106","journal-title":"Oncol Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2741\/4668","volume":"23","author":"Sartorius K.","year":"2018","unstructured":"Sartorius K.; Sartorius B.; Winkler C.; Chuturgoon A.; Makarova J.; The biological and diagnostic role of miRNA\u2019s in hepatocellular carcinoma. Front Biosci (Landmark Ed)  2018,23(9),1701-1720","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clinbiochem.2022.10.009","volume":"111","author":"Uzen R.","year":"2023","unstructured":"Uzen R.; Bayram F.; Dursun H.; Oxidative and chromosomal DNA damage in patients with type I Gaucher disease and carriers. Clin Biochem  2023,111,26-31","journal-title":"Clin Biochem"},{"key":"ref=27","unstructured":"miRBase: The microRNA database the archive for microRNA sequences and annotations."},{"key":"ref=28","first-page":"3818","volume":"7","author":"Zheng R.","year":"2014","unstructured":"Zheng R.; Jiang Y.; Wang X.; Role of microRNAs on therapy resistance in Non-Hodgkin \u2019 s lymphoma. Int J Clin Exp Med  2014,7(11),3818","journal-title":"Int J Clin Exp Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1002\/jcp.27776","volume":"234","author":"Mardani R.","year":"2018","unstructured":"Mardani R.; MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential. J Cell Physiol  2018,234(6),8465","journal-title":"J Cell Physiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.3390\/ijms19103139","volume":"19","author":"Di Marco M.","year":"2018","unstructured":"Di Marco M.; Ramassone A.; Pagotto S.; Anastasiadou E.; Veronese A.; Visone R.; MicroRNAs in autoimmunity and hematological malignancies. Int J Mol Sci  2018,19(10),3139","journal-title":"Int J Mol Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-3-319-40320-5","volume":"169","author":"Glavey SV","year":"2016","unstructured":"Glavey SV; Manier S; Sacco A; Epigenetics in multiple myeloma. Cancer Treat Res  2016,169,35-49","journal-title":"Cancer Treat Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcancer.2017.09.007","volume":"51","author":"Alzrigat M.","year":"2018","unstructured":"Alzrigat M.; P\u00e1rraga A.A.; Jernberg-wiklund H.; Seminars in cancer biology epigenetics in multiple myeloma: From mechanisms to therapy. Semin Cancer Biol  2018,51,101","journal-title":"Semin Cancer Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/cas.12160","volume":"104","author":"Tagawa H.","year":"2013","unstructured":"Tagawa H.; Ikeda S.; Sawada K.; Role of microRNA in the pathogenesis of malignant. Cancer Sci  2013,104(7),801-809","journal-title":"Cancer Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fonc.2019.00515","volume":"9","author":"Mei M.","year":"2019","unstructured":"Mei M.; Zhang M.; Non-coding RNAs in natural killer\/T-cell lymphoma. Front Oncol  2019,9,515","journal-title":"Front Oncol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature09284","volume":"467","author":"Medina P.P.","year":"2010","unstructured":"Medina P.P.; Nolde M.; Slack F.J.; OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature  2010,467(7311),86-90","journal-title":"Nature"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1186\/s40169-019-0230-0","volume":"8","author":"Toh T.B.","year":"2019","unstructured":"Toh T.B.; Lim J.J.; Chow E.K.H.; Chow H.; Epigenetics of hepatocellular carcinoma. Clin Transl Med  2019,8(1),e13","journal-title":"Clin Transl Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/leu.2011.81","volume":"25","author":"Watanabe A.","year":"2011","unstructured":"Watanabe A.; Tagawa H.; Yamashita J.; The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia  2011,25(8),1324-1334","journal-title":"Leukemia"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/ijms19123978","volume":"41","author":"Han T.","year":"2018","unstructured":"Han T.; Ban H.S.; Hur K.; The epigenetic regulation of HCC metastasis. J Exp Clin Cancer Res  2018,41,107","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3389\/fonc.2019.00900","volume":"9","author":"Bidarra D.","year":"2019","unstructured":"Bidarra D.; Const\u00e2ncio V.; Barros-Silva D.; Circulating MicroRNAs as biomarkers for prostate cancer detection and metastasis development prediction. Front Oncol  2019,9(September),900","journal-title":"Front Oncol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.seminoncol.2011.08.001","volume":"38","author":"Braconi C.","year":"2011","unstructured":"Braconi C.; Henry J.C.; Kogure T.; Schmittgen T.; Patel T.; The role of microRNAs in human liver cancers. Semin Oncol  2011,38(6),752-763","journal-title":"Semin Oncol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00277-011-1350-9","volume":"91","author":"Fang C.","year":"2012","unstructured":"Fang C.; Zhu D.X.; Dong H.J.; Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol  2012,91(4),553-559","journal-title":"Ann Hematol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"7928","DOI":"10.18632\/oncotarget.23974","volume":"9","author":"Hershkovitz-Rokah O.","year":"2018","unstructured":"Hershkovitz-Rokah O.; Geva P.; Salmon-Divon M.; Shpilberg O.; Liberman-Aronov S.; Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas. Oncotarget  2018,9(8),7928-7941","journal-title":"Oncotarget"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3892\/or.2015.4275","volume":"34","author":"Mao B.","year":"2015","unstructured":"Mao B.; Wang G.E.; MicroRNAs involved with hepatocellular carcinoma (Review). Oncol Rep  2015,34(6),2811-2820","journal-title":"Oncol Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.3748\/wjg.v24.i25.2647","volume":"24","author":"Vasuri F.","year":"2018","unstructured":"Vasuri F.; Visani M.; Acquaviva G.; Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World J Gastroenterol  2018,24(25),2647-2660","journal-title":"World J Gastroenterol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.3892\/ol.2017.5826","volume":"13","author":"Yan J.J.","year":"2017","unstructured":"Yan J.J.; Chang Y.; Zhang Y.N.; Lin J.S.; He X.X.; Huang H.J.; miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma. Oncol Lett  2017,13(5),3118-3126","journal-title":"Oncol Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"8726567","DOI":"10.1155\/2020\/8726567","volume":"2020","author":"Zhang H.","year":"2020","unstructured":"Zhang H.; Chen X.; Yuan Y.; Investigation of the miRNA and mRNA coexpression network and their prognostic value in hepatocellular carcinoma. BioMed Res Int  2020,2020(1),8726567","journal-title":"BioMed Res Int"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"108124","DOI":"10.1016\/j.intimp.2021.108124","volume":"100","author":"Xu Y.","year":"2021","unstructured":"Xu Y.; He Y.; Hu H.; The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease. Int Immunopharmacol  2021,100,108124","journal-title":"Int Immunopharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1080\/15476286.2014.996085","volume":"11","author":"Siebert M.","year":"2014","unstructured":"Siebert M.; Westbroek W.; Chen Y.C.; Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells. RNA Biol  2014,11(10),1291-1300","journal-title":"RNA Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nbd.2019.04.008","volume":"127","author":"Watson L.","year":"2019","unstructured":"Watson L.; Keatinge M.; Gegg M.; Ablation of the pro-inflammatory master regulator miR-155 does not mitigate neuroinflammation or neurodegeneration in a vertebrate model of Gaucher\u2019s disease. Neurobiol Dis  2019,127(April),563-569","journal-title":"Neurobiol Dis"}],"container-title":["MicroRNA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122115366342286250216032611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/239846\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122115366342286250216032611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T04:38:51Z","timestamp":1765427931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239846\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0122115366342286250216032611","relation":{},"ISSN":["2211-5366"],"issn-type":[{"type":"print","value":"2211-5366"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}